Drug profile · INN
simeprevir
OLYSIO
simeprevir (OLYSIO) is an FDA-listed pharmaceutical active ingredient.
EMA: withdrawn Antiinfectives for systemic use (J05) J05AE14
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — simeprevir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
simeprevir (OLYSIO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN simeprevir
Brand OLYSIO
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AE14
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is simeprevir?
simeprevir (OLYSIO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for simeprevir?
OLYSIO is a marketed brand name for simeprevir. Check FDA Drugs@FDA for the current US label holder and prescribing information.